In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

A novel coronavirus outbreak of global health concern

(2020) Chen Wang et al.   LANCET

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold

(2018) Katherine L. Seley-Radtke et al.   ANTIVIRAL RESEARCH

Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein

(2016) Chung-ke Chang et al.   DRUG DISCOVERY TODAY

Structural Basis for the Identification of the N-Terminal Domain of Coronavirus Nucleocapsid Protein as an Antiviral Target

(2014) Shing-Yen Lin et al.   JOURNAL OF MEDICINAL CHEMISTRY

Performance of the MM/GBSA scoring using a binding site hydrogen bond network-based frame selection: the protein kinase case

(2014) Francisco Adasme-Carreño et al.   PHYSICAL CHEMISTRY CHEMICAL PHYSICS

Molecular modeling, quantum polarized ligand docking and structure-based 3D-QSAR analysis of the imidazole series as dual AT1 and ETA receptor antagonists

(2013) Khuraijam Dhanachandra Singh et al.   ACTA PHARMACOLOGICA SINICA

Influenza virus nucleoprotein: structure, RNA binding, oligomerization and antiviral drug target

(2013) Sylvie Chenavas et al.   Future Microbiology

Health Benefits of Methylxanthines in Cacao and Chocolate

(2013) Rafael Franco et al.   Nutrients

Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery

(2012) Xuan-Yu Meng et al.   Current Computer-Aided Drug Design

Inhibition of HBV replication by theophylline

(2010) Zirui Zheng et al.   ANTIVIRAL RESEARCH